Literature DB >> 32376662

Looking beyond appearances: when liver biopsy is the key for hepatic tuberculosis diagnosis.

Marta Freitas1,2,3, Joana Magalhães4,2,3, Carla Marinho4,2,3, José Cotter4,2,3.   

Abstract

Primary hepatic tuberculosis is a rare clinical entity with non-specific clinical and imaging features that can mimic other liver diseases, representing a diagnostic challenge. We report a case of a 35-year-old man with metabolic syndrome, type 2 diabetes and high alcohol consumption presenting asymptomatic with abnormal liver tests, hepatosplenomegaly and diffuse hepatic steatosis in ultrasound imaging initially suspected to be alcoholic steatohepatitis but later diagnosed as hepatic tuberculosis in the histological specimen. Anti-tuberculosis therapy was started. This clinical case highlights the diagnostic difficulty of hepatic tuberculosis and the importance of not overlooking liver biopsy and to consider it in the differential diagnosis in patients with obvious hepatic injury factors but with atypical clinical presentation. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  alcoholic liver disease; liver disease; nonalcoholic steatosis

Mesh:

Substances:

Year:  2020        PMID: 32376662      PMCID: PMC7228446          DOI: 10.1136/bcr-2020-234491

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  22 in total

1.  Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers.

Authors:  Jean-Baptiste Trabut; Véronique Thépot; Bertrand Nalpas; Béatrice Lavielle; Simona Cosconea; Marion Corouge; Anaïs Vallet-Pichard; Hélène Fontaine; Vincent Mallet; Philippe Sogni; Stanislas Pol
Journal:  Alcohol Clin Exp Res       Date:  2012-03-08       Impact factor: 3.455

2.  Localized hepatic tuberculosis.

Authors:  Ali Mert; Resat Ozaras; Fehmi Tabak; Recep Ozturk; Muammer Bilir
Journal:  Eur J Intern Med       Date:  2003-12       Impact factor: 4.487

3.  Primary nodular hepatic tuberculosis mimicking hepatic neoplasia in an immunocompetent host.

Authors:  Levindo Tadeu Ferreira Figueiredo Dias; Gisane Cavalcanti Rodrigues; Diogo Santos Barbosa; Domício Carvalho Lacerda; Marcelo Freire Ruas
Journal:  Braz J Infect Dis       Date:  2009-04       Impact factor: 1.949

4.  Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases.

Authors:  B Coco; F Oliveri; A M Maina; P Ciccorossi; R Sacco; P Colombatto; F Bonino; M R Brunetto
Journal:  J Viral Hepat       Date:  2007-05       Impact factor: 3.728

5.  Comparison of in house polymerase chain reaction with conventional techniques for the detection of Mycobacterium tuberculosis DNA in granulomatous lymphadenopathy.

Authors:  K K Singh; M Muralidhar; A Kumar; T K Chattopadhyaya; K Kapila; M K Singh; S K Sharma; N K Jain; J S Tyagi
Journal:  J Clin Pathol       Date:  2000-05       Impact factor: 3.411

6.  Tuberculosis hepatitis: a clinical review of 96 cases.

Authors:  A R Essop; J A Posen; J H Hodkinson; I Segal
Journal:  Q J Med       Date:  1984

7.  Fulminant hepatic failure caused by tuberculosis.

Authors:  W Hussain; D Mutimer; R Harrison; S Hubscher; J Neuberger
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

8.  Primary hepatic tuberculosis: a rare but fatal clinical entity if undiagnosed.

Authors:  Sneh Singh; Promil Jain; Garima Aggarwal; Pratibha Dhiman; Sunita Singh; Rajeev Sen
Journal:  Asian Pac J Trop Med       Date:  2012-06       Impact factor: 1.226

Review 9.  Tuberculosis.

Authors:  Gary Maartens; Robert J Wilkinson
Journal:  Lancet       Date:  2007-12-15       Impact factor: 79.321

Review 10.  Hepatobiliary tuberculosis.

Authors:  Poras Chaudhary
Journal:  Ann Gastroenterol       Date:  2014
View more
  1 in total

1.  Clinical Manifestation, Imaging Features and Treatment Follow-up of 29 Cases with Hepatic Tubercolosis.

Authors:  Saiduo Liu; Wei Chen; Jichan Shi; Xinchun Ye; Hongye Ning; Ning Pan; Xiangao Jiang
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-09-01       Impact factor: 3.122

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.